Unihealth Hospitals Ltd

Unihealth Hosp Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Unihealth Hospitals Ltd

₹ 793 -0.40%
24 Jul - close price
unihealthonline.com NSE - SME: UNIHEALTH
About

Incorporated in 2010, Unihealth Consultancy Ltd is in the business of Medical Tour Operator and Health Consultancy Service & Trader in Medical Equipments[1]

Key Points

Business Overview:[1]
Headquartered in Mumbai, Unihealth Hospitals Ltd is a diversified healthcare service provider with a global presence, particularly in Africa. The company operates under the 'UMC Hospitals' brand and provides:
- Hospital and medical centre services,
- Healthcare consultancy and project management,
- Export and distribution of pharmaceutical and medical consumables,
- Medical value travel facilitation for international patients.

Website NSE - SM
  • Market Cap ₹ 1,260 Cr.
  • Current Price ₹ 793
  • High / Low ₹ 820 / 134
  • Stock P/E 194
  • Book Value ₹ 50.5
  • Dividend Yield 0.00 %
  • ROCE 12.0 %
  • ROE 8.89 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 50.0% CAGR over last 5 years

Cons

  • Stock is trading at 15.7 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 6.70% over last 3 years.
  • Earnings include an other income of Rs.6.69 Cr.
  • Company has high debtors of 254 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of Nifty SME Emerge

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
0.92 3.31 1.56 2.00 2.87 3.67
1.23 1.04 1.38 1.94 1.68 2.38
Operating Profit -0.31 2.27 0.18 0.06 1.19 1.29
OPM % -33.70% 68.58% 11.54% 3.00% 41.46% 35.15%
0.96 1.37 1.51 1.80 2.66 4.03
Interest 0.32 0.02 0.00 0.03 0.08 0.02
Depreciation 0.04 0.12 0.13 0.15 0.12 0.11
Profit before tax 0.29 3.50 1.56 1.68 3.65 5.19
Tax % -72.41% 27.43% 26.28% 28.57% 25.21% 27.17%
0.50 2.54 1.15 1.20 2.72 3.77
EPS in Rs 1.75 2.40
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.63 1.61 1.92 4.23 3.56 6.54
0.94 0.79 1.36 2.26 3.32 4.06
Operating Profit -0.31 0.82 0.56 1.97 0.24 2.48
OPM % -49.21% 50.93% 29.17% 46.57% 6.74% 37.92%
0.06 0.94 1.79 2.33 3.31 6.69
Interest 0.80 1.19 1.15 0.36 0.03 0.10
Depreciation 0.11 0.09 0.08 0.16 0.28 0.24
Profit before tax -1.16 0.48 1.12 3.78 3.24 8.83
Tax % 0.00% 0.00% -19.64% 19.84% 27.47% 26.50%
-1.16 0.48 1.34 3.04 2.35 6.49
EPS in Rs 4.13
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 60%
3 Years: 50%
TTM: 84%
Compounded Profit Growth
10 Years: %
5 Years: 50%
3 Years: 69%
TTM: 176%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 372%
Return on Equity
10 Years: %
5 Years: 7%
3 Years: 7%
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 1.34 1.34 1.39 15.40 15.40 15.70
Reserves 4.69 5.17 11.28 49.07 51.32 63.62
6.96 11.60 12.08 3.30 2.66 0.00
3.67 0.42 0.61 0.71 1.00 2.45
Total Liabilities 16.66 18.53 25.36 68.48 70.38 81.77
1.60 1.50 1.42 3.09 3.15 2.90
CWIP 0.00 0.00 0.00 0.00 0.00 0.00
Investments 6.15 6.15 6.34 18.37 30.50 30.49
8.91 10.88 17.60 47.02 36.73 48.38
Total Assets 16.66 18.53 25.36 68.48 70.38 81.77

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-0.32 2.25 1.97 -2.44 -0.83 4.03
0.06 -6.13 -7.17 -10.50 -8.07 -5.41
0.19 3.93 5.09 39.55 -0.58 4.32
Net Cash Flow -0.07 0.05 -0.11 26.61 -9.48 2.94
Free Cash Flow -0.29 2.25 1.97 -4.26 -1.17 4.04
CFO/OP 103% 274% 352% -96% 12% 256%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 857.46 476.09 117.86 225.21 298.36 254.50
Inventory Days 0.00 0.00
Days Payable
Cash Conversion Cycle 857.46 476.09 117.86 225.21 298.36 254.50
Working Capital Days 4,745.00 562.24 26.61 361.55 412.16 343.79
ROCE % 10.74% 10.59% 8.95% 4.77% 12.01%

Insights

In beta
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Revenue Share from Hospitals Segment (Business Mix)
%

Log in to view insights

Please log in to see hidden values.

Login
Revenue Share from Uganda (Geography Mix)
%
Total Operational Beds
Beds
Annual Procedures Done
Procedures
Beds Under Consultancy (Order Book)
Beds
Patients Treated Annually
Patients
Average Revenue Per Occupied Bed (ARPOB) - Uganda
INR per day
Bed Occupancy Rate - Uganda
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
68.80% 68.80% 68.93% 68.93% 69.14% 69.53%
5.61% 0.00% 0.00% 0.00% 0.00% 0.00%
3.31% 0.14% 0.02% 0.23% 0.75% 0.48%
22.27% 31.05% 31.05% 30.83% 30.11% 29.99%
No. of Shareholders 1,1119799849851,0581,162

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls